Vaccination-associated anaphylaxis in adults: Diagnostic testing ruling out IgE-mediated vaccine allergy

Vaccine

Volumn 27, Issue 29, 2009, Pages 3885-3889

  Seitz, Cornelia S ^a   Bröcker, Eva B ^a   Trautmann, Axel ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Adverse reaction; Challenge test; Re vaccination; Skin test; Vaccine

Indexed keywords

IMMUNOGLOBULIN E; VACCINE;

ADOLESCENT; ADULT; AGED; ALLERGY; ANAPHYLAXIS; ARTICLE; CHILD; CLINICAL ARTICLE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROVOCATION TEST; REVACCINATION; SCHOOL CHILD; SKIN TEST; VACCINATION;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; CHILD; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; SKIN TESTS; VACCINATION; YOUNG ADULT;

EID: 67349097386     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.04.020     Document Type: Article

References (30)

1. Siegrist C.A. Mechanisms underlying adverse reactions to vaccines. J Comp Pathol 137 Suppl. 1 (2007) S46-S50
2. Madaan A., and Maddox D.E. Vaccine allergy: diagnosis and management. Immunol Allergy Clin North Am 23 4 (2003) 555-588
3. Song B.J., and Katial R.K. Update on side effects from common vaccines. Curr Allergy Asthma Rep 4 6 (2004) 447-453
4. Joint Task Force on Practice Parameters: American Academy of Allergy, Asthma and Immunology. American College of Allergy, Asthma and Immunology. Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol 2005;115(Suppl. 3):S483-523.
5. Simons F.E., Frew A.J., Ansotegui I.J., Bochner B.S., Golden D.B., Finkelman F.D., et al. Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol 120 Suppl. 1 (2007) S2-24
6. Herman J.J., Radin R., and Schneiderman R. Allergic reactions to measles (rubeola) vaccine in patients hypersensitive to egg protein. J Pediatr 102 2 (1983) 196-199
7. Kelso J.M. The gelatin story. J Allergy Clin Immunol 103 2 (1999) 200-202
8. Kwittken P.L., Rosen S., and Sweinberg S.K. MMR vaccine and neomycin allergy. Am J Dis Child 147 2 (1993) 128-129
9. Johansson S.G., Hourihane J.O., Bousquet J., Bruijnzeel-Koomen C., Dreborg S., Haahtela T., et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 56 9 (2001) 813-824
10. Brown S.G. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 114 2 (2004) 371-376
11. Bernstein I.L., Li J.T., Bernstein D.I., Hamilton R., Spector S.L., Tan R., et al. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol 100 Suppl. 3 (2008) S1-148
12. Gruber C., and Niggemann B. A practical approach to immunization in atopic children. Allergy 57 6 (2002) 472-479
13. Bohlke K., Davis R.L., Marcy S.M., Braun M.M., DeStefano F., Black S.B., et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 112 4 (2003) 815-820
14. Alves R.R., Gaspar A., and Ferreira M.B. Allergic reactions to vaccines. Eur Ann Allergy Clin Immunol 39 8 (2007) 269-277
15. Miller J.R., Orgel H.A., and Meltzer E.O. The safety of egg-containing vaccines for egg-allergic patients. J Allergy Clin Immunol 71 6 (1983) 568-573
16. James J.M., Zeiger R.S., Lester M.R., Fasano M.B., Gern J.E., Mansfield L.E., et al. Safe administration of influenza vaccine to patients with egg allergy. J Pediatr 133 5 (1998) 624-628
17. Zeiger R.S. Current issues with influenza vaccination in egg allergy. J Allergy Clin Immunol 110 6 (2002) 834-840
18. DiMiceli L., Pool V., Kelso J.M., Shadomy S.V., and Iskander J. Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS). Vaccine 24 6 (2006) 703-707
19. Sakaguchi M., Ogura H., and Inouye S. IgE antibody to gelatin in children with immediate-type reactions to measles and mumps vaccines. J Allergy Clin Immunol 96 4 (1995) 563-565
20. Nakayama T., and Aizawa C. Change in gelatin content of vaccines associated with reduction in reports of allergic reactions. J Allergy Clin Immunol 106 3 (2000) 591-592
21. Sugai K., Shiga A., Okada K., Iwata T., Ogura H., Maekawa K., et al. Dermal testing of vaccines for children at high risk of allergies. Vaccine 25 17 (2007) 3454-3463
22. Kemp S.F., and Lockey R.F. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 110 3 (2002) 341-348
23. Barsky A.J., Saintfort R., Rogers M.P., and Borus J.F. Nonspecific medication side effects and the nocebo phenomenon. JAMA 287 5 (2002) 622-627
24. Berthelot J.M., Maugars Y., Abgrall M., and Prost A. Interindividual variations in beliefs about the placebo effect: a study in 300 rheumatology inpatients and 100 nurses. Joint Bone Spine 68 1 (2001) 65-70
25. Shepherd M. The placebo: from specificity to the non-specific and back. Psychol Med 23 3 (1993) 569-578
26. Clark P.I., and Leaverton P.E. Scientific and ethical issues in the use of placebo controls in clinical trials. Annu Rev Public Health 15 (1994) 19-38
27. Barsky A.J., and Borus J.F. Functional somatic syndromes. Ann Intern Med 130 11 (1999) 910-921
28. Cullinan P., Brown R., Field A., Hourihane J., Jones M., Kekwick R., et al. Latex allergy. A position paper of the British Society of Allergy and Clinical Immunology. Clin Exp Allergy 33 11 (2003) 1484-1499
29. Sampson H.A., Munoz-Furlong A., Campbell R.L., Adkinson Jr. N.F., Bock S.A., Branum A., et al. Second symposium on the definition and management of anaphylaxis: summary report. Ann Emerg Med 47 4 (2006) 373-380
30. Greenhawt M., and Akin C. Mastocytosis and allergy. Curr Opin Allergy Clin Immunol 7 5 (2007) 387-392